Seeking Alpha

The FDA's approval of Actavis' generic Adderall XR will be a positive for Watson Pharmaceuticals...

The FDA's approval of Actavis' generic Adderall XR will be a positive for Watson Pharmaceuticals (WPI +1%), which is acquiring the company, says Goldman. The firm says the news supports its above consensus earnings estimates, adding that it sees only modest impact to TEVA and IPXL.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)